Outcomes

Monroe Biomedical Research Acquired by New Harbor Capital in a First Step to Build-out a Clinical Research Site Platform

Monroe Biomedical Research Acquired by New Harbor Capital in a First Step to Build-out a Clinical Research Site Platform

Outcomes

SSI Strategy, a Portfolio Company of Amulet Capital Partners, Acquired NDA Group AB to Bolster Regulatory Affairs Consulting Capabilities and Expand Into the EU

SSI Strategy, a Portfolio Company of Amulet Capital Partners, Acquired NDA Group AB to Bolster Regulatory Affairs Consulting Capabilities and Expand Into the EU

Outcomes

Catalyst Clinical Research, a Portfolio Company of QHP Capital, Acquired Genpro Research to Expand Global Footprint and Deepen Service Offerings

Catalyst Clinical Research, a portfolio company of QHP Capital, acquired Genpro Research to expand global footprint and deepen service offerings

Outcomes

Accel Research Sites Network Acquired by Alcanza Clinical Research, a portfolio company of Martis Capital, to Expand its Clinical Trial Site Network and Clinical Trial Execution Capabilities

Accel Research Sites Network Acquired by Alcanza Clinical Research, a portfolio company of Martis Capital, to Expand its Clinical Trial Site Network and Clinical Trial Execution Capabilities

Outcomes

Benchmark Research Acquired by IQVIA, combined with Avacare to Expand Vaccine and Clinical Trial Site Capabilities

ClinChoice has acquired CROMSOURCE to expand their CRO capabilities globally.

Outcomes

Clinical Site Services and Patient Advertising Guru Acquired by American Clinical Research Services to Add Tech-Enabled Patient Recruitment Capabilities

Clinical Site Services and Patient Advertising Guru were acquired by American Clinical Research Services to add tech-enabled patient recruitment capabilities.

Outcomes

Clinical Site Services and Patient Advertising Guru Acquired by American Clinical Research Services to Add Tech-Enabled Patient Recruitment Capabilities

Clinical Site Services and Patient Advertising Guru were acquired by American Clinical Research Services to add tech-enabled patient recruitment capabilities.

Outcomes

ClinChoice Acquires CROMSOURCE to Expand CRO Capabilities Globally

ClinChoice has acquired CROMSOURCE to expand their CRO capabilities globally.

Outcomes

anteris Acquired by Kymanox, a Portfolio Company of Westview Capital Partners, to Expand Injectable Combination Product Development Capabilities Globally

Transaction helps both companies realize their shared goals of geographic expansion, while also bolstering service capabilities.